PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
This study introduces mesoscopic FLIm as a potential solution to address the challenge of residual cancer in Transoral Robotic Surgery. Current methods rely on intraoperative frozen sections analysis (IFSA), which can yield false negatives. FLIm utilizes tissue fluorophores to delineate head and neck cancer in the surgical cavity accurately. A FLIm-based semi-supervised classification model was developed using data from 22 patients, achieving a sensitivity of 0.75 for residual tumors and an overall tissue specificity of 0.78. The proposed approach also outperformed IFSA in detecting positive surgical margins. FLIm shows promise in guiding TORS and improving surgical outcomes.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
The alert did not successfully save. Please try again later.
Mohamed Hassan, Brent W. Weyers, Julien Bec, Jinyi Qi, Dorina Gui, Arnaud F. Bewley, Marianne Abouyared, Andrew C. Birkeland, Laura Marcu, "Mesoscopic FLIm for detection of residual cancer in transoral robotic surgery," Proc. SPIE PC12818, Imaging, Therapeutics, and Advanced Technology in Head and Neck Surgery and Otolaryngology 2024, (13 March 2024); https://doi.org/10.1117/12.3003627